Article List

WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2004> 7> 4

Volume: 7 Issue: 4

1. Clinical study on the metastatic patterns of lymph node in lung cancer.	Page:361—363
2. Long-term consecutive follow-up of high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation (APBSCT) in the treatment of small cell lung cancer.	Page:357—360
3. Comparative study of sputum sediment paraffin section and sputum smear examinations for diagnosis of lung cancer.	Page:354—356
4. Sequential variation of pulmonary flow spectrum and its value on the evaluation of risk for pulmonary resection in perioperative patients with lung cancer.	Page:351—353
5. Thoracoscopy and thoracotomy for lung biopsy and wedge resection in solitary pulmonary nodule.	Page:347—350
6. Expression of hypoxia inducible factor 1α and its clinical significance in non-small cell lung cancer.	Page:344—346
7. Different expressions of p53 gene family members and their clinical significance in human non-small cell lung cancer.	Page:339—343
8. Relationship of cytokine level with cancer cachexia and therapeutic effects of indomethacin for cancer cachexia.	Page:336—338
9. Effect of exogenous p73 gene on chemosensitivity of wild-type p53 human lung adenocarcinoma cell A549.	Page:331—335
10. Targeted Iressa therapy in patients with brain metastases from non-small cell lung cancer.	Page:329—330
11. Phase II clinical trial of homemade human rh-endostatin in the treatment of patients with stage IIIB-IV non-small cell lung cancer.	Page:325—328
12. Iressa for the non-small cell lung cancer patients who failed prior chemotherapy and radiotherapy.	Page:321—324
13. Gefitinib molecular target therapy for Chinese patients with non-small cell lung cancer.	Page:318—320
14. The salvage regimen for patients with advanced non-small cell lung cancer who failed prior chemotherapy: once-daily single oral agent Iressa.	Page:313—317
15. ZD1839 (Iressa) in the treatment of non-small cell lung cancer patients.	Page:309—312
16. Iressa for refractory non-small cell lung cancer: A preliminary report.	Page:305—308
17. Gefitinib is active in patients with brain metastasis from non-small cell lung cancer.	Page:298—304
18. Targeting blockage of Wnt signal transduction pathway of nm23-H1 gene transfection in human high-metastatic large cell lung cancer cell line L9981.	Page:294—297
19. Experimental study of tissue-specific suicide gene therapy for lung adenocarcinoma.	Page:290—293
20. Targeted therapy in non-small cell lung cancer.	Page:284—289
21. A new horizon of targeted therapy in management of lung cancer.	Page:276—283
22. Trend of molecular target therapy of non-small cell lung cancer.	Page:270—275
23. More attention should be devoted to molecular target therapy of lung cancer in our country.	Page:267—269